Director, Regulatory Operations @ (August 2025 - June 2026)
Director, Regulatory Operations and Publishing @ (February 2023 - May 2025)
Sr Director, Regulatory Operations @ (October 2022 - February 2023)
Senior Director, Regulatory Operations @ (August 2019 - October 2022)
Director, Regulatory Operations @ (April 2017 - August 2019)
Director, Regulatory Operations @ (February 2015 - April 2017)
Associate Director, Regulatory Operations @ (October 2011 - February 2015)
Manager, Regulatory Operations @ (August 2010 - October 2011)
Senior Associate, Regulatory Operations @ (July 2008 - August 2010)
Senior Associate, Regulatory Operations @ (September 2006 - July 2008)
Regulatory Affairs @ Acambis (January 2002 - January 2007)
Andy Wallen Education
University of Connecticut
Bachelor of Arts (English)
1988-1992
State University of New York Cortland
BS (Exercise Physiology)
Andy Wallen Skills
Regulatory Affairs
Regulatory Submissions
FDA
IND
Pharmaceutical Industry
Biotechnology
21 CFR Part 11
eCTD
Vaccines
GMP
Sop
Regulatory Requirements
Computer System Validation
GxP
Regulatory Operations
Regulations
Leadership
Document Management
SharePoint
Project Management Software
Office 365
Accountability
Electronic Common Technical Document (eCTD)
Organizational Culture
Regulatory Documentation
Strategic Planning
U.S. Food and Drug Administration (FDA)
U.S. Title 21 CFR Part 11 Regulation
Strategy
Pharmaceutical Sales
Sales Operations
Andy Wallen Summary
Andy Wallen, based in Boston, MA, US, is currently a Senior Director, Regulatory Operations at Crescent Biopharma. Andy Wallen brings experience from previous roles at BBOT, Mersana Therapeutics, Novo Nordisk and FORMA Therapeutics, Inc.. Andy Wallen holds a 1988 - 1992 Bachelor of Arts in English @ University of Connecticut. With a robust skill set that includes Regulatory Affairs, Regulatory Submissions, FDA, IND, Pharmaceutical Industry and more. Andy Wallen has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andy Wallen?
Find contact details for 700 million professionals.